The patient’s case was discussed by a multidisciplinary pediatric tumor board and is monitored by the pediatric oncology service with serial tumor marker levels (alpha fetoprotein (AFP), human chorionic gonadotrophin (HCG), and lactate dehydrogenase (LDH) immediately, then at 3, 6, 12, and 18 months of age) and surveillance MRIs at 3, 6, and 12 months of age with no sign of disease recurrence at 22 months of age. Here, AFP is linked to neoplasm.